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Background: There has been increasing interest in oxytocin (peptide: OT, gene:
OXT ) as a treatment pathway for neurodevelopmental disorders such as Autism
Spectrum Disorder (ASD). Neurodevelopmental disorders affect functional, social, and
intellectual abilities. With advances in molecular biology, research has connected multiple
gene regions to the clinical presentation of ASD. Studies have also shown that the
neuropeptide hormones OT and arginine vasopressin (AVP) influence mammalian social
and territorial behaviors and may have treatment potential for neurodevelopmental
disorders. Published data examining molecular and phenotypic variation in ASD, such as
cognitive abilities, are limited. Since most studies have focused on the receptors in the
OT-AVP system, we investigated genetic variation within peptide genes for association
with phenotypic ASD features that help identify subgroups within the spectrum.
Methods: In this study, TDT analysis was carried out utilizing FBAT in 207 probands
(156 trios) and a European Ancestry (EA) subsample (108 trios).The evolutionarily related
and adjacent genes of OXT and AVP were studied for associations between the tagged
single nucleotide polymorphisms and ASD diagnosis, social abilities, restrictive and
repetitive behaviors, and IQ for cognitive abilities. Additionally, relationships with whole
blood serotonin (WB5HT) were explored because of the developmental relationships
connecting plasma levels of OT and WB5HT within ASD.
Results: Results indicate significant association between OXT rs6084258 (p = 0.001)
and ASD. Associations with several endophenotypes were also noted: OXT rs6133010
was associated with IQ (full scale IQ, p = 0.008; nonverbal IQ, p = 0.010,
verbal IQ, p = 0.006); and OXT rs4813625 and OXT rs877172 were associated
with WB5HT levels (EA, p = 0.027 and p = 0.033, respectively). Additionally, we
measured plasma OT (pOT) levels in a subsample (N = 54). Results show the three
polymorphisms, OXT rs6084258, OXT rs11697250, and OXT rs877172, have significant
association with pOT (EA, p = 0.011, p = 0.010, and p = 0.002, respectively).
Francis et al. Genetic Variants in ASD Phenotypes
Conclusions: These findings suggest that SNPs near OXT and AVP are associated
with diagnosis of ASD, social behaviors, restricted and repetitive behaviors, IQ, pOT, and
WB5HT. Future studies need to replicate these findings and examine gene-interactions
in other neurodevelopmental disorders. Mechanisms of action may influence early social
and cognitive development that may or may not be limited to ASD diagnosis.
Keywords: oxytocin, vasopressin, ASD, genetics, polymorphisms, biomarkers, phenotypes, IQ
INTRODUCTION
The DSM-5 (American Psychiatric Association, 2013) describes
autism spectrum disorder (ASD) as a group of disorders
characterized by persistent deficits in social communication
and interaction across multiple contexts, and the presence of
restricted, repetitive patterns of behaviors (RRBs). It places ASD
within a larger category of neurodevelopmental disorders that
also includes intellectual disabilities, communication disorders,
attention-deficit/hyperactivity disorder, specific learning or
motor disorders, and others that continue on to adulthood.
ASD is heritable and highly heterogeneous with a complex
inheritance process (Bailey et al., 1995). Molecular technology
has allowed us to identify numerous contributions to ASD and
their related developmental features. Recent changes in DSM-
5 reflect a shift from discrete categorization toward broader
spectrum,multidimensional characterization of clinical disorders
including neurodevelopmental disorders.
Neurohypophysial hormones such as oxytocin (peptide: OT,
gene: OXT) and vasopressin (peptide: AVP, gene: AVP) have
been studied increasingly over the last decade, especially in
ASD. Located on chromosome 20, OXT and AVP are closely
linked and are positioned in opposite transcriptional orientations
approximately 10 kilobases (kb) apart. Recently, there was a study
reporting a replication of linkage in this 20p13 chromosome
region area for ASD risk genes (Weiss et al., 2009; Werling
et al., 2014). OT (and OXT) and AVP have been evolutionarily
conserved in both structure and function across a diverse range
of species, and are involved with social cognition and repetitive
behaviors (for review see Jacob et al., 2011). For example,
centrally administered OT (Carter et al., 1995) facilitated
partner-preference formation, whereas blocking the OT receptor
(OTR) inhibited the behavior in monogamous prairie voles.
Alternatively, AVP acting at the vasopressin-1A receptor can
induce repetitive aggressive behaviors; this effect of AVP was
blocked by the simultaneous use of a serotonin (5HT1A) agonist
(for review of animal studies see Carter and Jacob, 2012).
Receptor genes for OT and AVP have been researched to
examine relationships with many aspects of social behavior.
Parker et al. (2014) found the OT receptor gene (OXTR) SNP
rs2254298 to be associated with social impairment in both an
ASD and neurotypical sample. Recent studies have revealed a role
for the neuropeptide hormones in social withdrawal disorders
Abbreviations: EA, European Ancestry; pOT, Plasma Oxytocin; RRB(s),
Restrictive/Repetitive Behavior(s); SNP(s), Single Nucleotide Polymorphism(s);
WB5HT, Whole-blood Serotonin; WB5HTz, Whole-blood Serotonin z-score.
and as a potential treatment pathway for ASD and schizophrenia
(Pedersen et al., 1994; Kendrick et al., 1997; Wang and Young,
1997; Ferguson et al., 2000, 2001; Young, 2001; Carter, 2007;
Souza et al., 2010a,b; Teltsh et al., 2012; Anagnostou et al.,
2014). In ASD, there have been linkage and association studies
for OT and AVP pathway genes (for review see Francis et al.,
2014b) including the disruption of CD38, which is involved in
OT secretion (Lerer et al., 2010; Munesue et al., 2010; Ceroni
et al., 2014). The relationship between OT and ASD has also
been strengthened by research examining OT levels in plasma.
An early study showing that plasma OT (pOT) concentrations
were lower in children with ASD (Modahl et al., 1998), led to
an OT deficit model that has been tested in subsequent studies
with ASD populations with varying results. Several groups have
reported low pOT in ASD (Al-Ayadhi, 2005; Andari et al.,
2010), and others no difference (Miller et al., 2013) or high pOT
(Jansen et al., 2006) in ASD. Researchers have also shown that
lower pOT is associated with decreased social functioning within
neurotypical cohorts as well (Clark et al., 2013; Feldman et al.,
2014).
In individuals with ASD, we previously observed a
correlation between whole-blood serotonin and plasma OT
levels (Hammock et al., 2012). OT and serotonin (5-HT) were
negatively correlated with each other (p < 0.05) and this
relationship was most prominent in children less than 11 years
old. Of the many biomarkers studied in ASD, the oxytocinergic
and serotonergic systems have numerous connections. In animal
as well as human studies, both 5-HT and OT were able to
modulate the release of each other depending on brain location
(Sawchenko et al., 1983; Emiliano et al., 2007; Hammock et al.,
2012). In 2009, Yoshida et al. demonstrated modulation of 5-HT
in the raphe nuclei by the OT system (Yoshida et al., 2009).
The raphe nuclei are a core area of 5-HT synthesis. Recently,
in 2014, an imaging study utilized PET and a marked selective
5-HT1A antagonist to map the 5-HT1A system by administering
OT and placebo to healthy males (Mottolese et al., 2014). They
observed a decrease in extracellular 5-HT in the dorsal raphe
nucleus, amygdala-hippocampus-parahippocampus complex,
insula and orbitofrontal cortex (mid/ventral) noting that OT
modulated the serotoninergic system. It is hypothesized that the
amygdala-hippocampus complex may be where the interactions
of OT and 5-HT regulate responses to stress and anxiety.
Given our previous research regarding changes in whole-blood
serotonin (WB5HT) and plasma OT levels with puberty and
age, and other studies examining the interactions between the
oxytocinergic and serotonergic systems, further research is
required to understand the possible roles and interactions of
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these two systems as they relate to symptom domains in early
and later development.
As with studying the role of OT and AVP in social behavior,
OXTR was an initial point for researchers to begin exploring
the role of OT and AVP in ASD (Lerer et al., 2008; Tansey
et al., 2010; Wermter et al., 2010; Lakatosova et al., 2013). Two
recent meta-analyses have also reported associations between
OXTR and ASD (LoParo andWaldman, 2015; Kranz et al., 2016).
LoParo and colleagues analyzed data from eight studies and
11 independent samples, finding associations between ASD and
the OXTR single nucleotide polymorphisms (SNPs)—rs7632287,
rs2268491, and rs2254298. Our lab previously reported an
association between rs2254298 and ASD in a Caucasian sample
(Jacob et al., 2007). Kranz et al. (2016) analyzed two independent
German samples and 10 additional studies, finding an association
between ASD and rs237889. While we have focused on OT,
AVP, and their receptors, multiple genes and biomarkers are
involved with ASD risk. Researchers are finding ways to study
pathway interactions that contribute to specific phenotypes.
Intermediate phenotypes, also called endophenotypes, have
distinct heritable components of the overall disorder and reduce
heterogeneity (Gottesman and Gould, 2003). ASD researchers
often parse clinical heterogeneity by measuring levels of
social communication and restricted/repetitive behaviors (RRB)
subphenotypes in order to investigate underlying biological
systems more directly (Abrahams and Geschwind, 2008; Levin-
Decanini et al., 2013). These two quantitative traits have
phenotypic variability and can be attributed to many genes.
Although most of this work has focused on OXTR, two
OXT SNPs (rs2740210 and rs4813627) were associated with
maternal care giving measures (e.g., motherese vocalizations
during mother-infant interactions; Mileva-Seitz et al., 2013).
Given the roles of OT and AVP in social behavior, pathway
genes have been studied in parental behaviors, pair bonding,
social motivation, social memory, social preference, social
competence, empathy, social cognition or theory of mind, social
anxiety, and stress management with performance pressures
(for review see Meyer-Lindenberg et al., 2011; Feldman et al.,
2015).
Fewer human studies have examined RRB as a quantitative
phenotype with OT pathways genes, although recently a study of
OXT showed effect for repetitive as well as social subphenotypes
in the 3′UTR of the OT gene (Harrison et al., 2015). Animal
studies have also suggested that cognitive rigidity may be a RRB-
like subphenotype related to OXT and ASD (Sala et al., 2011).
Restricted/repetitive behaviors have a range of features including
compulsions, ritualistic/sameness, restricted, stereotyped, and
self-injurious behaviors that may be influenced by OT or AVP
pathways (for review see Francis et al., 2014a). Although, most
research has focused on the receptor genes, a few studies have
suggested that SNPs in OXT and AVP are associated with
RRBs. In a study of ASD and hormonal genes, OXT rs2740204
was associated with stereotyped behaviors but not overall
diagnosis (Yrigollen et al., 2008). Additionally, in 2009, Ebstein
and colleagues genotyped 170 subjects with ASD testing both
individual SNPs and haplotypes in OXT. Nominal associations
were observed between ASD and OXT rs6133010, as well as two-,
three-, and four-locus haplotypes. In a Swedish twin study, the
researchers observed an association between OXT rs2770378 and
autism-like traits including language impairment and restricted
behaviors in females but not males with ASD (Hovey et al., 2014).
There are also limited data on molecular associations
with discrepant cognitive abilities, another important ASD
endophenotype (Lerer et al., 2008; Chapman et al., 2011).
Intellectual disability as defined by the DSM-5 involves
impairments of general mental abilities that impact adaptive
functioning in everyday tasks across three domains (conceptual,
social and practical). The removal of IQ scores (IQ ≤ 70)
from the diagnostic criteria of intellectual disability, but still
including them in the text description, emphasizes that an
important aspect of a person’s intellect is a measure of his/her
overall general mental ability centered around social behavior,
which is the core deficit in ASD. Increased discrepancies
between performance and verbal IQ (cognitive profile) have
been observed in ASD individuals and have correlated with
core components of the ASD phenotype. A review of 23 studies
considering the cognitive profile of individuals with autism found
that verbal IQ (VIQ) is generally lower than performance IQ
(Lincoln et al., 1988), a pattern found in a recent study of
over 450 preschoolers with autism (Munson et al., 2008). This
decreased VIQ relative to performance IQ could be interpreted
as an indirect measure of social communication impairment. In
ASD research conducted in 2008, Lerer and colleagues found
a nominal yet significant association with IQ and two OXTR
SNPs (rs4686301 and rs1042778). Next they performed haplotype
analysis ranging from two to eight markers along a sliding
window. IQ was found to be significantly associated with several
haplotypes ranging across all haplotype lengths. Also when
IQ was entered as a covariate, significant associations were
observed with two OXTR SNPs (rs2268494 and rs1042778) and
ASD.
Given the previously published associations between the
OT-AVP system and behaviors and phenotypes in ASD, we
intend to further elicit associations between tagged SNPs
and haplotypes, and social behavior, ASD diagnosis, social
phenotypes, and IQ. Currently, there is very little functional
data about OT and AVP pathway gene SNPs and how they
relate to functional changes in human tissues, especially within
the brain. There is limited literature on receptor distribution,
cerebrospinal fluid, and neuroglial vesicular transport of OT
and AVP neuropeptides and the range of affected neurocircuits
in humans. Current studies are being done in human brain
pathology tissues using receptor ligands that have been
successful in non-human primates. We selected expression
quantitative trait loci (eQTL) analysis to investigate expression
as a first step in looking at functional expression changes.
We also explored these relationships in association with
two biomarkers: pOT and whole blood 5-HT (WB5HT).
The 5-HT and OT systems interact in the brain, both
during development and in adulthood. The separate lines of
evidence for blood 5-HT and OT measures as biomarkers in
ASD, coupled with the evidence for intersection between the
corresponding systems in the brain, led us to further examine this
relationship.
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MATERIALS AND METHODS
Participants
With the approval of the University of Illinois at Chicago
(UIC) Institutional Review Board (IRB#: 2007-0239; Title:
Interdisciplinary Studies of Insistence on Sameness (IS) in
Autism Spectrum Disorders (ASD)), subjects were recruited
through the Developmental Disorders Clinic of the UIC Institute
for Juvenile Research, referral from providers of autism services,
a website providing information about the study, and parent
advocacy organizations. Prior to the first session, all participants
were provided a description of the study to obtain informed
consent from adults able to consent for themselves, and parents
or guardians of minors and individuals unable to consent.
All subjects had a medical history and physical examination
performed by a pediatric neurologist or child psychiatrist, and
a psychiatric evaluation by a child psychiatrist experienced in
ASD. Probands were assessed utilizing the Autism Diagnostic
Observation Schedule (ADOS; Lord et al., 2000) and Autism
Diagnostic Interview—Revised (ADI-R; Lord et al., 1994) and
were required to meet ASD or autism criteria on the ADOS
and autism criteria or ASD criteria on the ADI-R; the ASD
diagnosis was confirmed by clinical consensus of a clinical
psychologist and child psychiatrist experienced in ASD diagnosis
in accordance with the DSM-IV-TRASD classification (including
autism, Asperger disorder, or pervasive developmental disorder-
not otherwise specified (PDD-NOS)). One hundred fifty-six
probands completed genotyping for both mothers and fathers
for the trio design. We had data from an additional 51
probands with only one genotyped parent. Some biological
measures like WB5HT are influenced by ethnicity therefore we
repeated analyses on a restricted sample (108 complete trios)
based on their European ancestry (EA). Race and ethnicity
information was obtained during an initial screening by parent
or self-report. Table 1 describes demographic data for the
entire sample and the EA subsample. The data supporting
the conclusions in this article are available through the NIH
sponsored database, National Database for Autism Research
(NDAR; https://ndar.nih.gov/study.html?id=404).
The IQ and social subphenotypes of the participants were
measured utilizing assessment tools appropriate for the subjects’
ages and abilities. The Differential Ability Scales, Second Edition
(DAS-II; Elliot, 2006) was the primary and preferred assessment
for preschool through adolescent age participants. Mullen Scales
of Early Learning (MSEL; Mullen, 1995) was administered
to individuals with low cognitive abilities, and the Wechsler
Abbreviated Scale of Intelligence (WASI; Wechsler, 1999) for
higher functioning subjects≥18 years of age. A standard IQ score
was calculated based on the norms of the various tests, measured
mental age(s), and chronological age. We assessed full-scale IQ
(FSIQ) in our study, and then subdivided FSIQ into verbal (VIQ)
and non-verbal IQ (NVIQ), which we examined separately.
Two instruments administered to assess social abilities were
the Aberrant Behavior Checklist Community Version (ABC-
CV; Aman et al., 1985) and the Social Responsiveness Scale
(SRS; Constantino and Todd, 2000). ABC-CV, a five-factor, 53
item assessment was completed by the parent or guardian with
TABLE 1 | Demographic description of the entire genotyped sample and
the genotyped European Ancestry (EA) subsample.
All Probands EA Probands
Number Genotyped 207 108
Average Age (years) 9.88 (±5.48 SD) 9.82 (±5.99 SD)
Sex 170 (82.1% male) 91 (84.3% male)
37 (17.9% female) 17 (15.7% female)
IQ MEASUREMENTS
Full-Scale IQ 79.9 (N = 193; ±24.0 SD) 83.9 (N = 103; ±24.0 SD)
Verbal IQ 77.5 (N = 196; ±26.0 SD) 83.6 (N = 102; ±26.2 SD)
Non-verbal IQ 82.1 (N = 204; ±23.9 SD) 85.5 (N = 108; ±23.1 SD)
The EA subsample utilized in the biomarker analysis was pulled from the original, full
dataset.
direct knowledge of the subject. This instrument, approved for
individuals between 6 and 54 years old, assessed symptoms
of irritability and agitation, social withdrawal (or lethargy),
stereotypic behavior, hyperactivity and non-compliance, and
inappropriate speech. To measure the severity of autism
symptoms in social settings, we utilized the SRS. The SRS is a
65 item assessment completed by the parent, teacher or caregiver
of individuals aged 4–18 years yielding a quantitative measure
of social ability. The areas assessed by the SRS include: social
awareness, social information processing, capacity for reciprocal
social communication, social anxiety/avoidance, and autistic
preoccupations and traits. The total score reflects the degree of
overall social impairment, and can distinguish children with ASD
from other child psychiatric conditions.
SNP Genotyping and Biomarkers
Tag SNPs were selected using data from the Caucasian CEU
samples of HapMap (Haploview v.4, release 21; Barrett et al.,
2005) and Tagger (de Bakker et al., 2005). The region spanned
the adjacent genes OXT and AVP, and a ±20 kb flanking region.
Other inclusion criteria were a minor allele frequency ≥0.10
and a pairwise r2 ≤ 0.80. rs6115776 in the most 5′ non-coding
region could not be genotyped and has not been reported in other
genetic association studies of OT-AVP genes. We successfully
genotyped 10 SNPs across OXT and AVP. Figure 1 display
the positions of the 10 genotyped SNPs and Supplementary
Table 1 gives the linkage disequilibrium (LD) information for
the four markers used in the haplotype. To genotype, DNA
was extracted from 10mL of blood using PureGene R© DNA
Purification Kit, then quantified with Quant-iTTMPicoGreen R©
dsDNA Assay (Invitrogen, Carlbad, CA), and finally the samples
were normalized to 10 ng/mL before genotyping.
Genotyping was performed, blinded to the affect status, family
relationship, and demographic data utilizing TaqMan R© SNP
genotyping assays (Applied Biosystems
TM
, Foster City, CA).
Standard TaqMan R© SNP genotyping protocols were observed
for PCR reactions. TaqMan R© PCR reactions were done with
2.50 µL Universal Master Mix Amperase R© UNG, 0.125 µL
TaqMan R© probemix and 2.375µLwater for a 5µL total volume.
PCR conditions (Applied BiosystemsTMGeneAmp R© PCR System
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FIGURE 1 | Schematic of neurohormone genes, OXT and AVP. Located on chromosome 20, OXT and AVP are closely positioned and in opposite transcriptional
orientations. The SNPs listed are the 10 genotyped SNPs utilized in this study. The bolded SNPs denote the SNPs used in the haplotype.
9700; Foster City, CA) were: oneAmpErase R© step at 50.0◦C
for 2min, one enzyme activation step at 95.0◦C for 10min,
40–99 alternating cycles of denaturation at 92.0◦C for 15 s,
and annealing and extension at 58.0◦C for 1min. Fluorescence
intensity of the final PCR product was measured using a Roche
Light Cycler Model 480-II (Hoffmann–La Roche AG, Basel,
Switzerland, and Roche Light Cycler 480 Gene Scanning Software
v.1.5, Basel, Switzerland).
In a subset of the sample, we were able to measure plasma
levels of OT, allowing us to examine the relationships between
pOT and the 10 tagged SNPs. From the 10mL blood draw, 1mL
aliquots of plasma were stored at −80◦C until analysis before
assaying with radioimmunoassay (RIA) methods (Hammock
et al., 2012). A relationship between OT and 5-HT has been
observed in both animal models and ASD human studies
(Hammock et al., 2012). To further explore this relationship,
we examined relationships between the OXT-AVP tag SNPs
and WB5HT levels. Whole-blood 5-HT was measured by high-
performance liquid chromatographywith fluorometric detection,
as described previously (Anderson et al., 1981). Intra-assay and
interassay coefficients of variation were 1.7 and 6.2%, respectively
(Hammock et al., 2012). For WB5HT analysis, individuals taking
medications that could potentially influence 5-HT as well as
other psychotropic medications were excluded from analyses. In
order to compare WB5HT values across age and race/ethnicity,
z-scores were generated while adjusting for pubertal status and
race/ethnicity. Pubertal status was determined based on their
Tanner scale (Marshall and Tanner, 1969, 1970) or chronological
age. Subjects were classified as pre-pubertal if their Tanner Scale
was either I or II and post-pubertal if their Tanner Scale was
greater than or equal to III. In the absence of a Tanner Scale (e.g.,
parents, young children, not examined), chronological age was
used to create the puberty variable. Subjects with a chronological
age less than 12 years were classified as pre-pubertal; whereas,
subjects whose chronological age were greater than or equal to
12 years were classified as post-pubertal.
Analysis
Before running the analyses, we checked for Mendelian
errors and Hardy-Weinberg equilibrium. Utilizing PLINK v1.07
(Purcell et al., 2007) all SNPs in both samples were in Hardy-
Weinberg equilibrium. Mendelian errors varied by SNP and
were excluded from analysis on a per SNP basis. Utilizing
FBAT, associations were examined between the tagged SNPs
and ASD diagnosis, IQ measures, WB5HT (z-score), pOT, and
other assessments measuring autism-related endophenotypes.
Quantitative FBAT was carried out using FBAT v2.0.3 (Laird
et al., 2000). Both dominant and additive models were tested. For
each continuous phenotype of interest, associations between age
and sex were explored, where significant, residuals after adjusting
for these covariates were used as the adjusted phenotype in FBAT.
If neither covariate was significant, residuals adjusted to the
sample mean were computed and analyzed using FBAT. FBAT
v2.0.3 was also used to test haplotype associations with ASD
diagnosis and measured assessments. Haplotypes were created
based upon significant associations in the 5′ region. Similar
to the SNP analysis, Mendelian errors were excluded from
analysis. After their findings, Hammock et al. (2012) suggested
further examination of the relationship between WB5HT and
pOT in a larger EA sample. We performed correlations and t-
tests to examine not only the relationship between pOT and
WB5HT, but also the relationship between these markers, age,
and pubertal status. As in the Hammock et al. study, pOT was
converted to fg/mL and log transformed to create a WB5HT-
pOT ratio (WB5HT/log(pOT)). The distribution of log(pOT)
and the ratio were tested utilizing SPSS v21 (IBM Corp Released
2012). Calculating the skewness z-score, both pre and post
pubertal log(pOT) and the WB5HT-pOT samples were found
to be normal with a z-score between −1.96 and 1.96. The
lowest score was −1.13 (post log(pOT)) and the highest score
was 0.52 (pre pOT). These results were confirmed by Shapiro-
Wilk analysis (all p-values were greater than 0.07). After the
analyses were conducted, we concluded that the biomarkers were
normally distributed in both groups. An unpaired t-test was used
to examine the relationship between the ratio and pubertal status.
Expression Quantitative Trait loci (eQTLs)
We used ScanDB (Gamazon et al., 2010) to further investigate
the functional impact of variants included in this study, which
did include data from the expression levels of OXT and AVP.
Specifically, we annotated genotyped variants (and SNPs in LD,
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r2 = 0.5, with genotyped variants) according to their association
with expression levels in a previously published study of eQTLs
in parietal and cerebellar brain regions (Chen et al., 2013). This
approach and database were selected because of our previous
research on enrichment of brain eQTL (Davis et al., 2012).
RESULTS
We examined associations between SNPs in OXT and AVP
with ASD diagnosis and intermediate, quantitative phenotypes
(Tables 2A,B). For the significant associations we found effect
sizes were relatively small (ϕc < 0.10, df = 1—utilized for ASD
diagnosis effect size; 0.016 < η2 < 0.129—utilized for remaining
significant phenotypes) for all analyses displayed in Tables 2A,B.
In the dominant model the most 5′ OXT tag SNP, rs6084258,
was associated with ASD diagnosis (p≤ 0.001). When restricting
the analysis to the more ethnically homogeneous EA subsample
the association remained significant for the A risk allele (p ≤
0.006). Next, we investigated SNP associations with quantitative
phenotypes of IQ (FSIQ, NVIQ, and VIQ), RRB, and social
communication. The A-allele of rs6133010, near the 5′ region was
found to be associated with lower FSIQ (p= 0.008), lower NVIQ
(p = 0.010) and lower VIQ (p = 0.006), using the dominant
model in FBAT. Similar to a previous ASD study (Yrigollen
et al., 2008), rs2740204 was associated with RRB (dominant
model: p = 0.036). There were two SNPs associated with social
communication, rs4813625 for ABC–Social Withdrawal (p =
0.001) and rs1410713 for ABC-Inappropriate Speech (p= 0.021)
in the dominant inheritance model. With Bonferroni correction
(p ≤ 0.05/10 or 0.005) for 10 tag SNPs, only rs6084258 (in EA
subsample for ASD diagnosis) and rs4813625 (in entire sample
for social withdrawal) remained significant.
Given our significant ASD diagnosis association with
rs6084258 and previously published associations with rs6133010
(Ebstein et al., 2009), we did haplotype analysis in the 5′ region
(Figure 1, Table 2). The four-marker haplotype (rs6084258-
rs4813625-rs877172-rs6133010) and all the permutations (two-
and three-marker haplotypes) were analyzed in the whole sample
(Table 3) and EA subsample (not shown). Haplotypes were
significantly associated with IQ difference (VIQ-NVIQ), VIQ and
social communication (ABC-Social Withdrawal and SRS Total).
When restricting to an EA sample, ADOS-RRB was significant
for rs877172G-rs6133010A (p = 0.035). These haplotype results
need to be replicated in a larger sample.
Analysis of the biomarkers in a homogenous sample (EA:
pOT N ≤ 54; WB5HT N ≤ 108) also yielded significant results
(Table 2B). rs4813625C (p = 0.027) and rs877172T (p = 0.033)
were found to be significantly associated with WB5HT with a
dominant inheritance model. In addition to the WB5HT results,
FBAT yielded significant associations (dominant model) with
pOT levels andOXT SNPs rs6084258G (p= 0.011), rs11697250A
(p = 0.010), and rs877172G (p = 0.002). Boxplots displaying
biomarker level in relation to genotype of the significant SNPs
are provided as Supplementary Figures (Supplementary Figures
1A–D, 2A–F). The correlations performed with the biomarkers
and age yielded a significantly negative correlation (r = −0.261;
N = 111; p = 0.003) between WB5HT and age. We also
conducted analyses performed in 2012 by Hammock and
colleagues in this larger sample and noted a significant
relationship with WB5HT/log(pOT) and pubertal status
[t(31.92) = 3.51, p = 0.001]. The previous results used 11 years
of age as an approximated pre-puberty cut-off whereas we used
Tanner Scale less than III given that Tanner Scale III is assessed
as mid-puberty in the literature.
Our final analyses looked at eQTLs to further investigate the
functional impact of variants included in this study. According
to eQTL annotations (Table 4), we found that genotyped variants
(and those SNPs in LD with genotyped variants) show a low
level of association with expression of nearby genes in parietal
lobe and cerebellum, suggesting possible mechanisms for these
variants. The best evidence for association with gene expression
came from rs6076466 cis-association with RBCK1 (p = 5.467e-
05), a ubiquitin-binding transcription factor. None of the variants
were associated with expression of OXT or AVP in either brain
region. These annotations should be interpreted with caution as
differential expression across the brain can influence the power to
detect SNP associations with expression levels. As more is known
about OT/AVP expression in different brain regions, analyses
should be expanded to compare regional differences. In addition,
our analysis with ScanDB did not allow us to determine effect
size for our finding; therefore follow up studies should not only
extend expression and functional research but include effect size
where possible.
DISCUSSION
A relationship between the neurohypophysial hormones, OT
and AVP, and their influence on social behaviors has been
established across many mammalian species. The involvement of
OXT andAVP in social behaviors has led investigators to research
their possible dysfunction in disorders with social deficits as a
major characteristic—including ASD and schizophrenia (Souza
et al., 2010a,b; Teltsh et al., 2012). Results further support a
connection between OXT-AVP and social behaviors, specifically
a relationship with ASD, a disorder with significant social
impairment. We investigated 10 tagged SNPs in OXT and AVP,
revealing an association with ASD diagnosis and other ASD-
related phenotypes such as IQ, RRB, and measures of sociality.
Blood biomarkers, WB5HT and pOT, were also measured
and analyzed, to determine mechanistic interactions with the
SNPs and to explore their relationship to each other. We also
combined SNPs to perform haplotype analysis picking four 5′
SNPs due to our findings with rs6084258 and previous findings
with rs6133010. Additionally, we included eQTLs, to investigate
expression in different brain areas.
Our approach in this study was to attempt to do deeper OT-
AVP pathway phenotyping than previous studies. We predicted
associations between OXT-AVP SNPs and phenotypes and blood
biomarkers in an ASD sample. The main finding was a significant
association with rs6084258 and ASD diagnosis. To date, there
have been few associations with this SNP related to ASD or other
phenotypes we researched. Another SNP of importance in this
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TABLE 2 | Significant associations.
Phenotype SNP p-value Inheritance Model Z Associated Allele Risk Allele
(A)
Diagnosis ASD OXT rs6084258 0.001 Dominant −3.30 G A
IQ FSIQ OXT rs6133010 0.008 Dominant −2.63 A A
NVIQ OXT rs6133010 0.010 Dominant −2.59 A A
VIQ OXT rs6133010 0.006 Dominant −2.78 A A
Restricted/Repetitive
Behaviors
ADOS—RRB OXT-AVP rs2740204 0.036 Dominant 2.10 T T
0.022 Additive 2.30 T T
Social
Communications
ABC—Social Withdrawal OXT rs4813625 0.001 Dominant −3.25 C G
0.001 Additive −3.41 C G
ABC—Inappropriate Speech OXT-AVP rs1410713 0.021 Dominant 2.31 A A
0.036 Additive 2.09 A A
SNP p-value Inheritance Model Z Associated Allele Risk Allele
(B)
WB5HT (z-score) OXT rs4813625 0.027 Dominant 2.21 C C
OXT rs877172 0.033 Dominant 2.14 T T
Plasma OT OXT rs6084258 0.011 Dominant −2.54 G G
OXT rs11697250 0.010 Dominant −2.57 A A
0.039 Additive −2.06 A A
OXT rs877172 0.002 Dominant −3.17 G G
0.005 Additive −2.82 G G
The OXT SNPs are located in the 5′ region of OXT and the OXT-AVP SNPs are located in the 3′ region between the two genes. SNPs in these areas have been shown to
be associated with ASD-related phenotypes in other studies. (A) summarizes the significant associations between tagged SNPs and ASD diagnosis and measured assessments
in the entire sample. (B) displays the significant SNPs from the biomarker (WB5HTz, pOT) analyses in an EA subsample (WB5HT: N ≤ 108; pOT: N ≤ 38). Boxplots have
been submitted as supplementary figures, to provide graphical detail about the associations between the significant SNPs and WB5HT (Supplementary Figures 1A–D) and pOT
(Supplementary Figures 2A–F).
TABLE 3 | Haplotype associations in the entire sample.
Phenotype Markers Haplotype p-value Inheritance Model Z
IQ Difference rs6084258 rs4813625 rs877172 rs6133010 G C G A 0.040 Additive 2.06
rs6084258 rs4813625 rs877172 G C G 0.040 Additive 2.06
rs4813625 rs877172 rs6133010 C G A 0.040 Additive 2.06
VIQ rs4813625 rs877172 rs6133010 C T A 0.045 Dominant −2.00
ABC—Social Withdrawal rs6084258 rs4813625 rs877172 rs6133010 G G G A 0.015 Additive 2.43
rs6084258 rs4813625 rs877172 G G G 0.015 Additive 2.43
G G T 0.050 Dominant 1.96
rs6084258 rs4813625 rs6133010 G G A 0.003 Additive 3.01
rs6084258 rs4813625 G G 0.002 Additive 3.08
rs6084258 rs6133010 G A 0.013 Additive 2.49
rs4813625 rs877172 rs6133010 G G A 0.015 Additive 2.44
rs4813625 rs6133010 G A 0.001 Additive 3.38
C A 0.028 Additive −2.20
SRS Total rs6084258 rs4813625 G C 0.046 Additive −2.00
Haplotypes created from four SNPs in the 5′ region of OXT were analyzed for associations with ASD diagnosis, quantitative phenotypes, and biomarkers. Analysis was performed
on the entire sample (shown) and an EA subsample (not shown). Each row lists a significant haplotype for each phenotype tested. Two specific combinations of markers,
rs6084258-rs4813625-rs877172 and rs4813625-rs6133010, had more than one significant haplotype for ABC—Social Withdrawal.
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TABLE 4 | Significant SNPs from eQTL analysis.
SNP Gene p-value cis/trans
CEREBELLUM
rs8184236 CDC25B 0.0043 cis
C20orf96 0.0042 cis
rs2326055 NOP56 0.0086 cis
SNORD57 0.0077 cis
PANK2 0.0084 cis
rs11087565 RASSF2 0.0097 cis
rs6076466 TCF15 0.0062 cis
RNF24 0.0052 cis
PARIETAL
rs8184236 LRRN4 0.005855 cis
rs6076466 RBCK1 5.467e-05 cis
GFRA4 0.0004464 cis
rs4815566 TMC2 0.003158 cis
CRLS1 0.0007546 cis
rs2326055 RBCK1 0.004095 cis
C20orf96 0.002497 cis
Genotyped variants displayed a low level of association with gene expression in the parietal
lobe and cerebellum. The bolded SNP denotes the most significant association found in
our analysis.
study was rs6133010, the most 3′ SNP of the analyzed haplotype.
While previous research found rs6133010 to be associated with
ASD diagnosis (Ebstein et al., 2009), our results showed a
significant association with IQ (FSIQ, VIQ, and NVIQ) within
our ASD sample. Another SNP of interest, rs2740204, has been
associated with pharmacological treatment response, negative
symptom improvement, and increased risk in schizophrenia
(Souza et al., 2010a,b). Our results with this SNP (rs2740204)
were similar to Yrigollen et al. (2008), who found an association
with rs2740204 and RRB in an ASD population as measured by
the ADI and ADI-R. We found an association with rs2740204
and RRBs as measured by ADOS in our sample. The SNP
rs4813625, found to be associated with ABC-Social Withdrawal,
has been implicated in both schizophrenia (Souza et al., 2010b)
and reactions to stress in a healthy population (Love et al., 2012).
Reported haplotype results can vary due to the combination
of markers analyzed or the variation within the study samples;
therefore, these results need to be interpreted with caution
and replicated across ethnically similar samples. The SNPs at
either end of our haplotype consisting of 5′ OXT SNPs were of
interest. Asmentioned above rs6084258 and rs6133010 have been
associated with diagnosis and different phenotypes as individual
SNPs in ASD samples. In this haplotype analysis, we noted that
when present, rs6084258G and rs6133010A were significantly
associated with IQ and social communication measures (as
assessed by ABC-CV and SRS).
With the relationship between OT and social behaviors, and
the involvement of 5-HT in ASD and other disorders established,
we performed additional analysis with pOT and WB5HT for
possible associations with the tagged SNPs. Previous studies have
also revealed a relationship between 5-HT and OT. Serotonin
was shown to modulate OT release by interacting with different
5-HT receptors in the hypothalamus, an area where OT is
primarily produced (Jørgensen et al., 2003). Lee et al. (2003)
also observed increased pOT levels in healthy subjects when
fenfluramine, a 5-HT agonist, was administered. In 2013, Dölen
et al. explored the role of OT and 5-HT in social reward
utilizing mice. They demonstrated that OT and 5-HT modify
the mesocorticolimbic circuit by depressing excitatory synapses
on to the nucleus accumbens, which is an important component
of the mesocorticolimbic circuit reward system. This system has
been implicated in rewarding behaviors that are key to survival,
such as eating, drinking, and reproduction. Dölen et al. (2013)
along with others, hypothesized that social interaction may be
such a behavior and therefore utilizing a similar system of
reward. Additionally, we have previously found a relationship
between pOT andWB5HT in children and adolescents with ASD
(Hammock et al., 2012). The findings above suggest interplay
between OT and 5-HT.
Due to these findings we wanted to further explore possible
interactions between the OT and 5-HT systems. Of note, the
SNP found to be significantly associated with ASD diagnosis
in this study (rs6084258) was also significantly associated with
pOT. Although associated with pOT, it is with the opposite
allele consistent with the negative correlation of the biomarker,
decreased pOT in ASD, in this study. rs877172 was also found to
be significantly associated with both blood biomarkers. rs877172
and rs4813625 (a SNP we found to be associated with both
social withdrawal and WB5HT) were found to be associated
with schizophrenia risk in the three-marker haplotype containing
rs4813625, 877172, and 3761248 (C-G-C; Souza et al., 2010b). In
order to assess the potential for a functional role of these variants
in the regulation of OT and AVP, we explored a previously
published eQTL analysis in both the cerebellar and parietal
brain region tissues (Davis et al., 2012). The most significant
association between a candidate SNP and gene expression was
in parietal tissue with mRNA expression of RBCK1. RBCK1 is
within a region of high linkage with ASD affection status and is
located near OXT and AVP on chromosome 20 (Werling et al.,
2014). Our results are consistent with limited mRNA expression
of OT and AVP in the parietal and cerebellar regions of donor
tissue samples in the Allen Brain Atlas (http://human.brain-
map.org/). In these few adult, donor samples, OXT and AVP
overexpression is highest within several hypothalamic regions.
Future studies on neuropathology need to extend expression and
functional research across developmental ages (fetal, early, pre
puberty, post puberty, adult) and sexes.
As with many SNP variant studies of complex human
disorders, there are some inconsistencies between our findings
and the literature. We found rs2740204 to be associated
with RRBs as measured by the ADOS, and rs6133010 to be
associated with IQ scores. Ebstein et al. (2009) found that
rs6133010 was associated with ASD diagnosis, and noted a
haplotype association between rs6084265 and ASD diagnosis,
IQ, and the Vineland. However, Hovey et al. (2014) found no
associations with autistic-like traits (as measured ASD scores in
the Autism-Tics, ADHD and other comorbidities inventory) and
rs6133010 or rs2740204. Variable results could be due to many
factors such as: heterogeneity of the ASD sample, diagnostic
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tool, age, sex, and ethnicity. By analyzing an EA subsample,
we were able to control for inconsistencies due to ethnic
diversity. In this subsample, rs6084258 remained significantly
associated with ASD diagnosis, along with rs4813625 remaining
associated with social withdrawal. Analysis of an EA subsample
was also performed with the biomarkers (WB5HT and pOT)
and haplotypes. Another factor could be the use of different
assessments that may be identifying different aspects of similar
behaviors.
Methodology could be a contributing factor to inconsistent
findings in biomarker analysis, as discussed by McCullough
et al. (2013) and Szeto et al. (2011). Over the past two decades
investigators have reported higher pOT in ASD adults (Jansen
et al., 2006), lower pOT in ASD individuals (Modahl et al., 1998;
Andari et al., 2010; Yang et al., 2015), and no differences between
ASD and non-ASD subjects (Miller et al., 2013) utilizing both
enzyme immunoassay (EIA) and RIA. Taurines et al. (2014)
found children with ADHD have lower pOT than age-matched
typically developing or ASD children who had similar pOT levels.
Limited, variable and changing antibodies, RIA vs. EIA, and
differing collection and extraction methods influence outcomes
along with differences between laboratory-generated RIA and
commercially produced RIA and EIA kits. Variation in the age
of the sampled population also affects results. In 1998, a study
performed by Kumar and colleagues noted higher platelet 5-HT
and its metabolite 5-HIAA in older vs. younger women (Kumar
et al., 1998). Two points discussed by the authors in Hammock
et al. (2012) were utilizing the Tanner scale or sex hormone status
to further examine the relationship of 5-HT and pOT through
development, and to replicate the study in a larger sample. In this
study we addressed these points, finding a significant negative
correlation with pubertal status (lower WB5HT post puberty) in
a larger EA sample.
As with all studies, we had limitations to our research. Our
ethnically heterogeneous sample is relatively small for genetic
studies and our findings need to be replicated in larger samples.
Given potential sex differences in the OT-AVP systems and in
ASD (Carter and Jacob, 2012), future studies should include
a larger female sample allowing researchers to explore these
differences in detail. Future replications would also need to
use a consistent OT plasma measuring methodology given the
variability in the literature. There is a need in biomarker fields
to determine a consistent protocol across studies, including
extraction methodology and similar antibody sources until even
more standardized proteomic methods are developed in lieu
of immunoassays. Another limitation of our research is the
preliminary nature of our eQTL analysis. A larger sample is
needed for replication of our results, as well as, a deeper
analysis comparing results from different databases, and possible
differences in expression across age and between sexes.
The OT and AVP systems evolved in mammals to modulate
various biobehavioral processes, including selective social
bonding (e.g., pair, parent) and repetitive, territorial behaviors.
Although, more is known about receptor distribution in
animal brains, limited data is available about human brain
pathways. Modulatory neurohormones like OT and 5-HT are
likely to influence different neurocircuitry that affects social
communication, RRBs, and learning/IQ. Therefore, it is possible
that OT-AVP genes may influence multiple phenotypes. As
dimensional approaches are taken with DSM-5 and the Research
Domain Criteria (RDoC), further studies are needed to examine
the multiple and overlapping circuitries of these and other
phenotypes, such as the role of neuropeptide hormones in a range
of disorders with social deficits. As seen in previous research there
was overlap with SNP results in ASD and schizophrenia, although
future studies will need to use the same measures of social
and negative symptoms across disorders. Our study, along with
others, have found pOT variation in ASD, social communication
deficits in language, RRBs, ADHD, parental bonding, and trust in
both patient and non-patient populations. Given that OT-AVP
involvement could be related to phenotypes across disorders,
other neurochemical systems are highly likely to be involved
in these complex phenotypes. Future directions should examine
involvement of interactive neurotransmitter systems. In 2013,
Romero-Fernandez et al. found a rat dopamine-OT heteromer
receptor (D2R-OTR; Romero-Fernandez et al., 2013), and Love
et al. (2012) noted rs4813625 was found to modulate dopamine
release in females under stress conditions. A 2015 study by
Yang et al. examined the relationship between RRBs and the
neurochemicals OT, 5-HT and cortisol (CORT). They found,
in individuals with ASD, the levels of CORT, OT, and 5-HT
were significantly associated with RBS-R total score. Within
the domains of the assessment, CORT was positively associated
with stereotyped and restricted behaviors, 5-HT with stereotypy
and self-injurious behavior, and OT was negatively associated
with compulsive, sameness and restricted behavior subscales.
In addition, reverse translational animal studies may elucidate
pathway mechanisms but note that results may differ across
species (Bales et al., 2014). Our current study connects OT-
AVP genes to ASD and several endophentypes. This intermediate
phenotype approach will be important to examine the complex
and intricate interplay between neurochemicals systems involved
in neurodevelopmental disorders like ASD.
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